China bribery scandal may affect pharma's emerging markets

10/15/2013 | Pharmalot

Several global pharmaceutical firms have acknowledged that the bribery scandal in China has slowed sales, but their chief concern is whether it will affect business in such emerging markets as Brazil, Russia and India, where growth had been slowing before the bribery issue arose. One-third of Sanofi's revenue comes from emerging markets, compared to approximately 26% for Roche, GlaxoSmithKline and Novartis.

View Full Article in:

Pharmalot

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations